Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Novel Adjuvanted Hepatitis B Vaccine vs Engerix-B in Healthy Adults
NCT00697853Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 1998
- Primary completion
- Jul 1999
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of hepatitis b vaccine recombinant in hepatitis B (HBV) (5 arms), sponsored by GSK. Primary endpoint: Anti-HBs antibody concentrations at Month 7. Started Nov 1998; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00697853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00697853.